Related references
Note: Only part of the references are listed.T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
Enfu Hui et al.
SCIENCE (2017)
Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent
Alice O. Kamphorst et al.
SCIENCE (2017)
ISA-2011B, a Phosphatidylinositol 4-Phosphate 5-Kinase α Inhibitor, impairs CD28-Dependent Costimulatory and Pro-inflammatory Signals in Human T Lymphocytes
Martina Kunkl et al.
FRONTIERS IN IMMUNOLOGY (2017)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
Claudio G. Brunstein et al.
BLOOD (2016)
CD28 costimulatory signals in T lymphocyte activation: Emerging functions beyond a qualitative and quantitative support to TCR signalling
Nicla Porciello et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
CD28 Costimulation: From Mechanism to Therapy
Jonathan H. Esensten et al.
IMMUNITY (2016)
Phosphatidylinositol 4-Phosphate 5-Kinase β Controls Recruitment of Lipid Rafts into the Immunological Synapse
Marinos Kallikourdis et al.
JOURNAL OF IMMUNOLOGY (2016)
First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases
Aldo Borroto et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse Model
Sabrina Weissmueller et al.
PLOS ONE (2016)
Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor
Ruijun Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Phosphatidylinositol 4-Phosphate 5-Kinase α and Vav1 Mutual Cooperation in CD28-Mediated Actin Remodeling and Signaling Functions
Michela Muscolini et al.
JOURNAL OF IMMUNOLOGY (2015)
Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08
Paula Tabares et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes
Cristina Camperio et al.
IMMUNOLOGY LETTERS (2014)
T Cell Receptor Signaling Can Directly Enhance the Avidity of CD28 Ligand Binding
Mariano Sanchez-Lockhart et al.
PLOS ONE (2014)
Phosphatidylinositol 4-Phosphate 5-Kinase a Activation Critically Contributes to CD28-Dependent Signaling Responses
Michela Muscolini et al.
JOURNAL OF IMMUNOLOGY (2013)
Phosphotyrosine recognition domains: the typical, the atypical and the versatile
Tomonori Kaneko et al.
CELL COMMUNICATION AND SIGNALING (2012)
Mechanism and function of Vav1 localisation in TCR signalling
Olga Ksionda et al.
JOURNAL OF CELL SCIENCE (2012)
Association of CD28 IVS3+17T/C polymorphism with soluble CD28 in rheumatoid arthritis
I. Y. Ledezma-Lozano et al.
DISEASE MARKERS (2011)
A novel association between filamin A and NF-κB inducing kinase couples CD28 to inhibitor of NF-κB kinase α and NF-κB activation
Michela Muscolini et al.
IMMUNOLOGY LETTERS (2011)
NF-κB family of transcription factors: Biochemical players of CD28 co-stimulation
Loretta Tuosto
IMMUNOLOGY LETTERS (2011)
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells
D. Eastwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cooperative interactions at the SLP-76 complex are critical for actin polymerization
Mira Barda-Saad et al.
EMBO JOURNAL (2010)
An Enigmatic Tail of CD28 Signaling
Jonathan S. Boomer et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Nck adapter proteins: functional versatility in T cells
Marcus Lettau et al.
CELL COMMUNICATION AND SIGNALING (2009)
CD28 and CTLA-4 coreceptor expression and signal transduction
Christopher E. Rudd et al.
IMMUNOLOGICAL REVIEWS (2009)
CD28 superagonists: What makes the difference in humans?
Burkhart Schraven et al.
IMMUNITY (2008)
FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes
Cristiano Scotta et al.
JOURNAL OF IMMUNOLOGY (2008)
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
Zoe Waibler et al.
PLOS ONE (2008)
Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease
R. Gunesacar et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2007)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation
Ryosuke Watanabe et al.
JOURNAL OF IMMUNOLOGY (2006)
Superagonistic anti-CD28 antibodies:: potent activators of regulatory T cells for the therapy of autoimmune diseases
N Beyersdorf et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Vav-family proteins in T-cell signalling
VL Tybulewicz
CURRENT OPINION IN IMMUNOLOGY (2005)
Dynamic molecular interactions linking the T cell antigen receptor to the actin cytoskeleton
M Barda-Saad et al.
NATURE IMMUNOLOGY (2005)
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-κB subunits on IL-8 and Bcl-xL gene promotors
B Marinari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
SLP-76 coordinates Nck-dependent Wiskott-Aldrich syndrome protein recruitment with Vav-1/Cdc42-dependent Wiskott-Aldrich syndrome protein activation at the T cell-APC contact site
R Zeng et al.
JOURNAL OF IMMUNOLOGY (2003)
Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
CH Lin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Recruitment of Nck by CD3ε reveals a Ligand-Induced conformational change essential for T cell receptor signaling and synapse formation
D Gil et al.
CELL (2002)
CD28 signaling via VAV/SLP-76 adaptors: Regulation of cytokine transcription independent of TCR ligation
M Raab et al.
IMMUNITY (2001)
Share Paper
